Hanmi Pharmaceutical Company Limited
Clinical trials sponsored by Hanmi Pharmaceutical Company Limited, explained in plain language.
-
New hope for tough stomach cancers: experimental combo targets Hard-to-Treat cases
Disease control CompletedThis study tested whether adding an experimental drug called FLX475 to an existing immunotherapy (pembrolizumab) could help control advanced stomach cancer. It enrolled about 90 patients whose cancer had progressed despite previous treatments, including separate groups based on t…
Phase: PHASE2 • Sponsor: Hanmi Pharmaceutical Company Limited • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
New back pain pill tested against standard treatment
Symptom relief CompletedThis study tested if a new pain medication called HCP1004 works as well as an existing drug, RLD2401, for people with long-term low back pain. It involved 310 adults who had experienced pain for at least 3 months. The main goal was to see if the new drug provided similar pain rel…
Phase: PHASE3 • Sponsor: Hanmi Pharmaceutical Company Limited • Aim: Symptom relief
Last updated Mar 27, 2026 12:38 UTC